Gene · 2280
Papers1,820
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,820
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrins and their potential roles in mammalian pregnancy. | J Anim Sci Biotechnol | 2023 | 37679778 | PubTator, text mining | PubMed |
| Drosophila Adducin facilitates phase separation and function of a conserved spindle orientation complex. | Front Cell Dev Biol | 2023 | 37655159 | PubTator, text mining | PubMed |
| Modeling specific aneuploidies: from karyotype manipulations to biological insights. | Chromosome Res | 2023 | 37640903 | PubTator, text mining | PubMed |
| Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma. | Pharmaceutics | 2023 | 37631344 | PubTator, text mining | PubMed |
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
| Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts. | BMC Nephrol | 2023 | 37626301 | PubTator, text mining | PubMed |
| Circ_0088212 Targeting miR-576-5p/FKBP1A Axis Inhibits Osteosarcoma Progression. | Ann Clin Lab Sci | 2023 | 37625838 | PubTator, text mining | PubMed |
| Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine. | J Alzheimers Dis | 2023 | 37574739 | PubTator, text mining | PubMed |
| Multicenter, 2-dose single-group controlled trial of tacrolimus for the severe infertility patients. | Medicine (Baltimore) | 2023 | 37565878 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health. | PLoS One | 2023 | 37556419 | PubTator, text mining | PubMed |
| Cancer-keeper genes as therapeutic targets. | iScience | 2023 | 37520717 | PubTator, text mining | PubMed |
| Cognitive Impairment in Multiple Sclerosis. | Bioengineering (Basel) | 2023 | 37508898 | PubTator, text mining | PubMed |
| Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets. | Cells | 2023 | 37508582 | PubTator, text mining | PubMed |
| Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK). | J Enzyme Inhib Med Chem | 2023 | 37489050 | PubTator, text mining | PubMed |
| Rab6-mediated retrograde trafficking from the Golgi: the trouble with tubules. | Small GTPases | 2023 | 37488775 | PubTator, text mining | PubMed |
| The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease. | Curr Neurovasc Res | 2023 | 37488757 | PubTator, text mining | PubMed |
| Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte. | Int J Med Sci | 2023 | 37484811 | PubTator, text mining | PubMed |
| Rapamycin treatment induces tubular proteinuria: role of megalin-mediated protein reabsorption. | Front Pharmacol | 2023 | 37484026 | PubTator, text mining | PubMed |
| HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expression. | Int J Mol Med | 2023 | 37477145 | PubTator, text mining | PubMed |
| Opto-RhoGEFs, an optimized optogenetic toolbox to reversibly control Rho GTPase activity on a global to subcellular scale, enabling precise control over vascular endothelial barrier strength. | Elife | 2023 | 37449837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2280/papers?page=7